The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dispersyn Gerrit since year 2005.
The trader's CIK number is 1704417.
At the time of this reporting, Dispersyn Gerrit is the Chief Development Officer of Rxi Pharmaceuticals Corp .
(stock ticker symbol RXII).
See this page for all insider trading activities at Rxi Pharmaceuticals Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-23||RXII||Rxi Pharmaceuticals Corp||Buy||3,500||.62||2,170|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dispersyn Gerrit (Chief Development Officer of Rxi Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.